Farmoquimica p.cls-Normal {
 text-align:justify;
 font-family:'Times New Roman', 'serif';
 font-size:12pt;
 line-height:108%;
 margin-top:0pt;
 margin-left:0pt;
 margin-right:0pt;
 margin-bottom:.001pt;
}
span.cls-DefaultParagraphFont {
 font-family:'Times New Roman', 'serif';
 font-size:12pt;
 font-weight:normal;
 margin:0in;
 padding:0in;
}
p.cls-Normal-000000 {
 text-align:left;
 font-family:'Times New Roman', 'serif';
 font-size:12pt;
 line-height:108%;
 margin-top:0pt;
 margin-left:0pt;
 margin-right:0pt;
 margin-bottom:.001pt;
}
span.cls-000001 {
 font-size:12pt;
 font-weight:normal;
 margin:0in;
 padding:0in;
}
p.cls-NormalWeb {
 margin-top:5pt;
 margin-bottom:5pt;
 text-align:left;
 font-family:'Times New Roman', 'serif';
 font-size:12pt;
 line-height:108%;
 margin-left:0pt;
 margin-right:0pt;
}
table { border-collapse:collapse !important; width:100%; table-layout:fixed; border-spacing:0 !important; margin-bottom:15px; } .k-table, .k-table td, table, table td, div table, div table td {outline: 0;border: 1px solid #000;} .k-table td, table td, div table td { padding: 5px;} 
 
 
  
  
  Farmoquimica ('FQM' or the 'Company') is seeking a USD 116 million A and B loan long term facilities from IFC (being USD 31 million for IFCs own account) to support the business combination between FQM and Divcom and finance the acquisition of brands commercialized by Divcom.  
  
  
    
  
  
  Founded in 1932 in Rio de Janeiro, FQM is one of Brazils pharma company operating in the segment of prescription drugs. Currently operating in 9 therapeutical areas including gastroenterology, respiratory, cardiology and dermatology, the Company has a portfolio of over 50 branded drugs. It has grown through both organic and inorganic growth with the recent acquisitions of Invictus (2012) and Melora (2016). 
  
  
  Divcom is a company manufacturing and distributing OTC products in Brazil and based in Pernambuco (Northeast Brazil). 
  
  
    
  
  
  This will be the first IFC project with this client. - Expand access to high quality and affordable pharmaceutical products. The project will help the expansion of a company that is one of the largest supplier of medicines for endemic diseases in Brazil (FQM #1 product is Annita, market leader for the treatment of parasitosis, endemic particularly in North and Northeast Brazil and other regions where access to clean drinkable water is not universal); 
- Support investments in frontier regions in Brazil, which suffer from restricted access to quality drugs at affordable rates. Divcom is entirely based in the Northeast region having the distribution center in Paraiba and manufacturing plant in Pernambuco. Already today, the North and Northeast of Brazil are #1 regions of operations of both FQM and Divcom.
- Support companies manufacturing their products in deprived areas (FQM plant is in JacarÃ© (RJ), and Vidfarma plant is located in the countryside of Pernambuco state), with a positive impact on employment of the local community. 
- Job creation for women. The company expects to expand its salesforces, a large part of which consists of women. 
- Support an attractive South-South investment from the controlling shareholder, LaboratÃ³rios Roemmers.